SEC 1473 | POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER | |
FORM 3 (Print or Type Responses) |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response .... 0.5 |
1. | Name and Address of Reporting Person* | 2. | Date of Event Requiring Statement (Month/Day/Year) |
4. | Issuer Name and Ticker or Trading Symbol | |||||||||||||||
Scarbrough | Elizabeth | A | November 14, 2002 | MacroPore Biosurgery, Inc. | ||||||||||||||||
(Last) | (First) | (Middle) | 3. | IRS Identification Number of Reporting Person, if an entity (voluntary) | 5. | Relationship of Reporting Person(s) to Issuer (Check all applicable) | 6. | If Amendment, Date of Original (Month/Day/Year) |
||||||||||||
Director | 10% Owner | |||||||||||||||||||
6740 Top Gun Street (Street) |
X Officer (give title below) |
Other (specify below) |
||||||||||||||||||
San Diego | CA | 92121 | V.P. Marketing & Development / Biologics | 7. | Individual or Joint/Group Filing | |||||||||||||||
(Check Applicable Line) | ||||||||||||||||||||
(City) | (State) | (Zip) | X Form filed by One Reporting Person Form filed by More than One Reporting Person |
Table I Non-Derivative Securities Beneficially Owned
1. | Title of Security (Instr. 4) |
2. | Amount of Securities Beneficially Owned (Instr. 4) |
3. | Ownership Form: Direct (D) or Indirect (I) (Instr. 5) |
4. | Nature of Indirect Beneficial Ownership (Instr. 5) |
|||||||
POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
Table II Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible
securities)
1. | Title of Derivative Security (Instr. 4) |
2. | Date Exercisable and Expiration Date (Month/Day/Year) |
3. | Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. | Conversion or Exercise Price of Derivative Security | 5. | Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. | Nature of Indirect Beneficial Ownership (Instr. 5) |
|||||||||||||||
Date Exercisable |
Expiration Date |
Title | Amount or Number of Shares | |||||||||||||||||||||||
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
Explanation of Responses:
/s/ Elizabeth Scarbrough | November 15, 2002 | |
**Signature of Reporting Person |
Date |
*If the form is filed by more than one reporting person, see Instruction 5(b)(v)
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.